# Monotherapy of an NMDA Enhancer for Schizophrenia

> **NCT04745143** · PHASE2 · RECRUITING · sponsor: **China Medical University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** NMDAE
- **DRUG:** Placebo Cap

## Key facts

- **NCT ID:** NCT04745143
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-01-01
- **Primary completion:** 2027-09
- **Final completion:** 2027-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04745143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04745143, "Monotherapy of an NMDA Enhancer for Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04745143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*